Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (991-1000 of 1,066) with videos related to

Pageof 107
Sort By:
Leukemia|November 27, 2012
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemiaA Mims, A R Walker, X Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral TherapyChelsea Bolyard, W Hans Meisen, Yeshavanth Banasavadi-Siddegowda, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
PTEN is a negative regulator of NK cell cytolytic functionEdward L Briercheck, Rossana Trotta, Li Chen, et al.
Nature|October 18, 2019
Habenular TCF7L2 links nicotine addiction to diabetesAlexander Duncan, Mary P Heyer, Masago Ishikawa, et al.
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2023
Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcomaMartyna W Sroka, Damianos Skopelitis, Marit W Vermunt, et al.
Blood|November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutationsSebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Nature|August 2, 2019
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasionAnna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Pageof 107

Showing results (991-1000 of 1,066) with videos related to

Sort By:
Pageof 107
Leukemia|November 27, 2012
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemiaA Mims, A R Walker, X Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral TherapyChelsea Bolyard, W Hans Meisen, Yeshavanth Banasavadi-Siddegowda, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
PTEN is a negative regulator of NK cell cytolytic functionEdward L Briercheck, Rossana Trotta, Li Chen, et al.
Nature|October 18, 2019
Habenular TCF7L2 links nicotine addiction to diabetesAlexander Duncan, Mary P Heyer, Masago Ishikawa, et al.
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2023
Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcomaMartyna W Sroka, Damianos Skopelitis, Marit W Vermunt, et al.
Blood|November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutationsSebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Nature|August 2, 2019
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasionAnna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Pageof 107